Thiopurine S-methyltransferase pharmacogenetics: Genotype to phenotype correlation in the Slovenian population

Pharmacology

Volumn 77, Issue 3, 2006, Pages 105-114

  Milek, M ^a   Murn, J ^a   Jaksic, Z ^a,c   Lukac Bajalo, J ^a   Jazbec, J ^b   Mlinaric Rascan, I ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Genetic polymorphism; Pharmacogenetics; Slovenian population; Thiopurine S methyltransferase

Indexed keywords

METHYLTRANSFERASE; THIOPURINE S METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; PHARMACOGENETICS; POPULATION GENETICS; PRIORITY JOURNAL; SLOVENIA; WILD TYPE;

DNA; GENE FREQUENCY; GENOTYPE; HUMANS; METHYLTRANSFERASES; PHARMACOGENETICS; PHENOTYPE; PURINES; SLOVENIA;

EID: 33746325458     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093278     Document Type: Article

References (46)

1. Lennard L: The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol 1992;43:329-339.
2. Chrzanowska M, Kolecki P, Duczmal-Cichocka B, Fiet J: Metabolites of mercaptopurine in red blood cells: a relationship between 6-thioguanine nucleotides and 6-methylmercaptopurine metabolite concentrations in children with lymphoblastic leukaemia. Eur J Pharm Sci 1999;8:329-334.
3. Otterness D, Szumlanski C, Lennard L, Klemetsdal B, Aarbakke J, Park-Hah JO, Iven H, Schmiegelow K, Branum E, O'Brien J, Weinshilboum R: Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther 1997;62:60-73.
4. Evans WE: Pharmacogenomics: marshalling the human genome to individualise drug therapy. Gut 2003;52(suppl II):ii10-ii18.
5. Lennard L, Van Loon JA, Lilleyman JS, Weinshilboum RM: Thiopurine pharmacogenetics in leukaemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin Pharmacol Ther 1987;41:18-25.
6. Weinshilboum R: Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab Dispos 2001;29:601-605.
7. Dervieux T, Blanco JG, Krynetski EY, Vanin EF, Roussel MF, Relling MV: Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukaemic cells. Cancer Res 2001;61:5810-5816.
8. Tiede I, Fritz G, Strand S, Poppe D, Dvorsky D, Strand D, Lehr HA, Wirtz S, Becker C, Atreya R, Mudter J, Hildner K, Bartsch B, Holtmann M, Blumberg R, Walczak H, Iven H, Galle PR, Ahmadian MR, Neurath MF: CD28-dependent Rac-1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 2003;111:1133-1146.
9. Weinshilboum RM, Sladek SL: Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980;32:651-662.
10. Seki T, Tanaka T, Nakamura Y: Genomic structure and multiple single-nucleotide polymorphism (SNPs) of the thiopurine S-methyltransferase (TPMT) gene. J Hum Genet 2000;45:299-302.
11. Szumlanski C, Otterness D, Her C, Lee D, Brandriff B, Kelsell D, Spurr N, Lennard L, Wieben E, Weinshilboum R: Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol 1996;15:17-30.
12. Schaeffeler E, Fischer C, Brockmeier D, Wernet D, Moerike K, Eichelbaum M, Zanger UM, Schwab M: Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 2004;14:407-417.
13. Salavaggione OE, Wang L, Wiepert M, Yee VC, Weinshilboum RM: Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics. Pharmacogenet Genomics 2005;15:801-815.
14. Tai HL, Krynetski EY, Schuetz EG, Yanishevski Y, Evans WE: Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. Proc Natl Acad Sci USA 1997;94:6444-6449.
15. Scheuermann TH, Lolis E, Hodsdon ME: Tertiary structure of thiopurine methyltransferase from Pseudomonas syringae, a bacterial orthologue of a polymorphic, drug-metabolizing enzyme. J Mol Biol 2003;333:573-585.
16. WangL, Sullivan W, Toft D, Weinshilboum R: Thiopurine S-methyltransferase pharmacogenetics: chaperone protein association and allozyme degradation. Pharmacogenetics 2003;13:555-564.
17. Collie-Duguid ESR, Pritchard SC, Powrie RH, Sludden J, Collier DA, Li T, McLeod HL: The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 1999;9:37-42.
18. Zhang JP, Guan YY, Wu JH, Xu AL, Zhou S, Huang M: Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groups. Br J Clin Pharmacol 2004;58:163-168.
19. Zhang JP, Guan YY, Xu AL, Zhou SF, Wu JH, Wei H, Huang M: Gene mutation of thiopurine S-methyltransferase in Uygur Chinese. Eur J Clin Pharmacol 2004;60:1-3.
20. Kham SK, Tan PL, Tay AH, Heng CK, Yeoh AE, Quah TC: Thiopurine methyltransferase polymorphisms in a multiracial Asian population and children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2002;24:353-359.
21. McLeod HL, Pritchard SC, Githang'a J, Indalo A, Ameyaw MM, Powrie RH, Booth L, Collie-Duguid ES: Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics 1999;9:773-776.
22. Krynetski EY, Tai HL, Yates CR, Fessing MY, Loennechen T, Schuetz JD, Relling MV, Evans WE: Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics 1996;6:279-290.
23. Lennard L, Lilleyman JS, Van Loon JA, Weinshilboum RM: Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia. Lancet 1990;336:225-229.
24. Evans WE, Horner MH, Chu YQ, Kalwinsky D, Roberts WM: Altered mercaptopurine metabolism, toxic effects and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphoblastic leukemia. J Pediatr 1991;119:985-989.
25. Loennechen T, Utsi E, Ingeborg H, Lysaa R, Kildalsen H, Aarbakke J: Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern Norway. Clin Pharmacol Ther 2001;70:183-188.
26. Relling MV, Dervieux T: Pharmacogenetics and cancer therapy. Nat Rev Cancer 2001;1:99-107.
27. Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M, Welte K, Ludwig WD, Bartram CR, Zanger UM, Eichelbaum M, Schrappe M, Schwab M: Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 2005;293:1485-1489.
28. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
29. Hiratsuka M, Inoue T, Omori F, Agatsuma Y, Mizugaki M: Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population. Mutat Res 2000;448:91-95.
30. Keizer-Garritsen JJ, Brouver C, Lambooy LHJ, Riet PT, Bökerrink JPM, Trijbels FJM, De Abreu RA: Measurement of thiopurine S-methyltransferase activity in human blood samples based on high-performance liquid chromatography: reference values in erythrocytes from children. Ann Clin Biochem 2003;40:86-93.
31. Spire-Vayron de la MC, Debuysere H, Mastain B, Vinner E, Marez D, Lo Guidice JM, Chevalier D, Brique S, Motte K, Colombel JF, Turck D, Noel C, Flipo RM, Pol A, Lhermitte M, Lafitte JJ, Libersa C, Broly F: Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br J Pharmacol 1998;125:879-887.
32. Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE: Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997;126:608-614.
33. Wusk B, Kullak-Ublick GA, Rammert C, von Eckardstein A, Fried M, Rentsch KM: Thiopurine S-methyltransferase polymorphisms: efficient screening method for patients considering taking thiopurine drugs. Eur J Clin Pharmacol 2004;60:5-10.
34. Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE: Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genet 1999;8:371-376.
35. Larovere LE, de Kremer RD, Lambooy LH, De Abreu RA: Genetic polymorphism of thiopurine S-methyltransferase in Argentina. Ann Clin Biochem 2003;40:388-393.
36. Reis M, Santoro A, Suarez-Kurtz G: Thiopurine methyltransferase phenotypes and genotypes in Brazilians. Pharmacogenetics 2003;13:371-373.
37. Boson WL, Romano-Silva MA, Correa H, Falcao RP, Teixeira-Vidigal PV, De Marco L: Thiopurine methyltransferase polymorphisms in a Brazilian population. Pharmacogenomics J 2003;3:178-182.
38. Isaza C, Henao J, Lopez AM, Cacabelos R: Allelic variants of the thiopurine methyltransferase (TPMT) gene in the Colombian population. Methods Find Exp Clin Pharmacol 2003;25:423-429.
39. Hamdy SI, Hiratsuka M, Narahara K, Endo N, El-Enany M, Moursi N, Ahmed MS, Mizugaki M: Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol 2003;55:560-569.
40. Ganiere-Monteil C, Medard Y, Lejus C, Bruneau B, Pineau A, Fenneteau O, Bourin M, Jacqz-Aigrain E: Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age. Eur J Clin Pharmacol 2004;60:89-96.
41. Ameyaw MM, Collie-Duguid ES, Powrie RH, Ofori-Adjei D, McLeod HL: Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet 1999;8:367-370.
42. Rossi AM, Bianchi M, Guarnieri C, Barale R, Pacifici GM: Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. Eur J Clin Pharmacol 2001;57:51-54.
43. Wei H, Zhou S, Li C, Zhang J, Wu J, Huang M: Phenotyping and genotyping studies of thiopurine S-methyltransferase in Kazaks. Pharm Res 2005;22:1762-1766.
44. Alves S, Prata MJ, Ferreira F, Amorim A: Thiopurine methyltransferase pharmacogenetics: alternative molecular diagnosis and preliminary data from Northern Portugal. Pharmacogenetics 1999;9:257-261.
45. Kurzawski M, Gaweonska-Szklarz B, Drozdzik M: Frequency distribution of thiopurine S-methyltransferase alleles in a Polish population. Ther Drug Monit 2004;26:541-545.
46. Haglund S, Lindqvist M, Almer S, Peterson C, Taipalensuu J: Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. Clin Chem 2004;50:288-295.